Close Menu

Over at In the Pipeline, Derek Lowe comments on the fact that slowly but surely, Merck has been getting many of the large Vioxx judgments against it overturned on appeal. Out of 20 that went to court, Merck has won 17. Part of the problem, says Lowe, is that the bad effects (heart attacks) happened to only a few people, compared to the total number who were taking the drug, many of whom didn't need it.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.